A detailed history of Capital Performance Advisors LLP transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 250 shares of ASRT stock, worth $205. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Holding current value
$205
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$1.07 - $1.75 $267 - $437
250 New
250 $0

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $39.5M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Capital Performance Advisors LLP Portfolio

Follow Capital Performance Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Performance Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Capital Performance Advisors LLP with notifications on news.